Evidence map›Paper›PMID 38134434›Full record

ArticleAnnals of the American Thoracic Society2024

Risk of 30-Day All-Cause Readmission in Interstitial Lung Disease Patients after COVID-19: National-Level Data.

Ali Vaeli Zadeh, Roshan Dinparastisaleh, Atefeh Vaezi, Debabrata Bandyopadhyay, Israel Rubinstein, Hassan Z Baig, Rafael Calderon-Candelario, Abdolrazagh Hashemi Shahraki, Takeshi Kawasaki, Jesper M Magnusson and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Annals of the American Thoracic Society, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. The Saga of COVID-19 in Chronic Lung Disease: History Repeats Itself.Annals of the American Thoracic Society · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Ali Vaeli ZadehUniversity of Miami at Holy Cross Health, Fort Lauderdale, Florida.
Roshan DinparastisalehDivision of Pulmonary, Critical Care, and Sleep, College of Medicine - Jacksonville, University of Florida, Jacksonville, Florida.ORCID 0000-0001-5285-2422
Atefeh VaeziDivision of Pulmonary, Critical Care, and Sleep, College of Medicine - Jacksonville, University of Florida, Jacksonville, Florida.
Debabrata BandyopadhyayDepartment of Medicine and.
Israel RubinsteinDivision of Pulmonary, Critical Care, Sleep, and Allergy, Department of Medicine, University of Illinois at Chicago, Illinois.
Hassan Z BaigDivision of Pulmonary, Allergy and Sleep Medicine, Department of Internal Medicine, Mayo Clinic, Jacksonville, Florida.
Rafael Calderon-CandelarioUniversity of Miami Miller School of Medicine, Miami, Florida.
Abdolrazagh Hashemi ShahrakiDivision of Pulmonary, Critical Care, and Sleep, College of Medicine - Jacksonville, University of Florida, Jacksonville, Florida.
Takeshi KawasakiChiba University, Chiba, Japan.ORCID 0000-0002-1468-172X
Jesper M MagnussonDepartment of Pulmonology, Institute of Medicine, Shagreens Academy, University of Gothenburg, Gothenburg, Sweden.
Lars-Olof LarssonDivision of Respiratory Medicine, Department of Medicine, Karolinska University Hospital, Stockholm, Sweden; and.
Amir SharafkhanehDepartment of Medicine, Pulmonary, Critical Medicine and Sleep Medicine, Baylor College of Medicine, Houston, Texas.
Jose D Herazo-MayaDepartment of Internal Medicine, University of South Florida, Tampa, Florida.
Augustine S LeeDivision of Pulmonary, Allergy and Sleep Medicine, Department of Internal Medicine, Mayo Clinic, Jacksonville, Florida.
Mehdi MirsaeidiDivision of Pulmonary, Critical Care, and Sleep, College of Medicine - Jacksonville, University of Florida, Jacksonville, Florida.ORCID 0000-0001-5298-8442

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Lung Diseases, InterstitialPneumoniaAdultAftercareCohort StudiesHumansPatient DischargePatient ReadmissionQuality of LifeUnited StatesCOVID-19interstitiallung diseasesmortalitypatient readmission

Identifiers

PMID38134434
PMCPMC10913765

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.